Myriad Genetics
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Newsroom
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Newsroom
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Category: Breast Cancer

Breast Cancer > Page 2
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Diversity
    • Employee Spotlight
    • EndoPredict
    • Equity
    • GeneSight
    • Genetic Counselors
    • Gynecologic Cancer
    • Hereditary Cancer
    • Inclusion
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • Myriad Employees
    • Myriad Science and Facilities
    • MyRisk
    • Neuroscience
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Blog
    • Patient Story
    • Patient-Featured
    • Prenatal care
    • Prenatal Screening (NIPS)
    • Prequel
    • Prolaris
    • Prostate Cancer
    • Provider Blog
    • Uncategorized
    • Urology
    • Women's Health

ASCO 2021 Preview: Making Breast Cancer Risk Assessment More Inclusive

May 20, 2021

We are already looking forward to one of the biggest cancer-focused conferences of the year: the annual meeting of the American Society of Clinical Oncology. Th...

Continue Reading

3 Tips to Help You Prevent Breast Cancer

October 1, 2019 Continue Reading

EndoPredict is the Only Test to Answer Three Critical Questions

December 7, 2018

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine...

Continue Reading

Genetic Testing Helps Personalize Breast Cancer Treatment Decisions

October 1, 2018

According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime.  In 2018, about 266,000 new cases of breast...

Continue Reading

BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer

January 23, 2018

The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breas...

Continue Reading

Andrea’s story: Cancer prevention can begin with knowing your family history

October 10, 2017

Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29 years old.  Losing my dad when I was so youn...

Continue Reading
Endopredict Patient Types

EndoPredict is now available in the U.S. (Infographic)

March 13, 2017

[caption id="attachment_14739" align="alignright" width="399"] EndoPredict now available in the U.S. (Infographic)[/caption] Introducing a More Accurate Breast...

Continue Reading

Team Myriad Raises Funds for the ACS Making Strides Against Breast Cancer Walk

October 12, 2015

Myriadians are passionate about saving and improving the lives of patients worldwide with our breakthrough molecular diagnostic tests. That commitment extends b...

Continue Reading

The Importance of Companion Diagnostics in Cancer and Beyond

June 1, 2015

It’s been wonderful to watch the evolution of medicine over the course of my career. Twenty years ago, when I finished my training in gynecologic oncology (th...

Continue Reading

Heidi Believes in the Value of Genetic Testing

October 22, 2014

I have always felt lucky. My husband and I met in college when I was just 18 and were married shortly after graduation. We have an incredible relationship, a st...

Continue Reading

Myriad Holds Event to Support Patient Advocacy Groups

September 26, 2014

The evening of September 19th was a night filled with an abundance of fun and meaning in the Big Easy. A total of 200 genetic counselors attended Myriad Genetic...

Continue Reading

After Her TNBC Diagnosis, Stephanie Made Life Affirming Choices

March 3, 2014

I have always been an optimist, a glass half-full type of person. So when I found a lump in my breast during a self-exam, I was sure that it was just a cyst. It...

Continue Reading

Michelle Encourages Patients to Actively Participate in Their Cancer Treatment

February 28, 2014

As I looked at the pathology report bearing my name and the words “poorly differentiated ductal carcinoma of the left breast,” feelings of overwhel...

Continue Reading

Shawna Talks About How She Dealt with a BRCA2 Mutation

February 6, 2014

In April 2010, I tested positive for the BRCA2 mutation. I am a mammogram technologist so I have seen firsthand the devastation that breast cancer can<br cau...

Continue Reading

Kim Knows the Importance of Talking about Hereditary Cancer

November 25, 2013

There’s a funny scene in the 1985 film, St. Elmo’s Fire, when Billy (Rob Lowe) is having dinner at the family home of his date for the evening, Wendy (Mare ...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Newsroom
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • HIPAA Notice of Privacy Practices
  • Provider Portal Terms of Use
  • Privacy Notice
  • Patents
  • Health Privacy Notice
  • Compliance and Code of Conduct
  • Notice of Nondiscrimination and Discrimination Grievance Procedure
  • IT Security
  • Notice of Access to Language Assistance Services
  • Cookie Preferences
facebook linkedin x X/Twitter social network instagram youtube
  • © 2025 Myriad Genetics, Inc.

Locations

United States
Europe
Japan